People behind CELLnTEC



Thomas Schnibbe serves as the Chief Executive Officer of CELLnTEC. Dr. Schnibbe has over 20 years of international experience in the life sciences, diagnostics and pharmaceutical industry, covering reagents, instruments and regulated products. Prior to joining CELLnTEC, he was an industry advisor and Partner with Simon & Sterling. Prior, Dr. Schnibbe served at QIAGEN where he held various managerial and leadership positions in Marketing, Sales and Strategy in Europe and the United States, most recently as Senior Director and head of the company’s Applied Testing business and member of QIAGEN’s Senior Management Team. Earlier, Dr. Schnibbe held commercial and product management roles at Chiron, now part of Novartis. Thomas Schnibbe holds a M.Sc. in Biotechnology with studies at Technical University of Braunschweig, Germany, and Kyoto University, Japan. He obtained a Ph.D. from the Max-Planck-Institute for Molecular Genetics / Free University Berlin.


Eliane J. Müller is founder and President of CELLnTEC and serves as chairman of the company’s Supervisory Board. She is Head of the Molecular Dermatology and Stem Cell Research group and the founder and chair of the Stem Cell and Regenerative Medicine Platform at the University of Bern and Insel, Bern University Hospital. In these functions, Prof. Müller brings a wide network and wealth of experience in the fields of dermatology and stem cell research to the company.  Her research focusses on the elucidation of signals governing epidermal renewal from stem cells to differentiated keratinocytes, and how these signals malfunction in specific skin diseases. Translational research by nature, her work has the ultimate goal of developing novel and specific therapeutic applications based on an improved understanding of the detailed mechanisms the skin uses to renew itself. Prior to joining the Bern University and Bern University Hospital, Prof. Müller was a postdoctoral fellow at the Faculty of Medicine, University of Sherbrooke, Canada and at the Institute of Cell Biology, University of Fribourg, Switzerland. Prof. Müller obtained a Ph.D. from the University of Fribourg in Molecular Biology and habilitated at the University of Bern in Cell Biology.


Peter Girling is co-founder and former CEO of CELLnTEC, and one of the key advisors to the company. He led the company from its inception until 2016, guiding both the technical development of advanced in vitro products and services, as well as the growth of the business through direct sales and marketing and the establishment of a broad distribution network across North America, Europe, and Asia. Mr. Girling earned his B.Sc. in Applied Science / Biology from the University of Tasmania, Australia, and conducted post-graduate biomedical research at UCSF / San Francisco General Hospital, USA and the University of Bern, Switzerland. He has also completed business and entrepreneurship programs at Babson College, USA, at EPFL Lausanne and USI Lugano, Switzerland.